Laser treatment for lichen sclerosus
Part of Skin clinical trials.
This study tests a laser treatment for women with vulvar lichen sclerosus to see if it can help with symptoms like itching, burning, pain, or soreness. It's a option for those who have had a biopsy to confirm the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 18 or older
- You have lichen sclerosus that was confirmed by a biopsy (a small skin sample test)
- You have at least one symptom like dryness, itching, burning, pain during sex, or sores
- You are not pregnant, nursing, or planning to become pregnant
- You do not have a current vaginal infection or a weakened immune system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if laser therapy works as well as clobetasol cream for vulvar lichen sclerosus after a previous course of the cream. It aims to offer an alternative treatment option for people who have already completed the standard cream therapy.
This study compares two treatments—clobetasol steroid cream or a fractional CO2 laser—for women with vulvar lichen sclerosus who have not used steroid cream before. It looks at how inflammation changes after treatment.
This study tests a new injectable medication called nemolizumab to see if it can reduce itching in women with lichen sclerosus affecting the genital area. If you have severe itching that hasn't been fully controlled by steroid creams, this might be an option to explore.
This study compares a new non-invasive treatment using radiofrequency energy to a standard steroid cream for women with vulvar lichen sclerosus. The goal is to see which works better for symptom relief.
This study compares three different treatments for vulvar lichen sclerosus (a skin condition that can cause itching and pain in the vulvar area): a steroid ointment, a calcineurin inhibitor ointment, and platelet-rich plasma (PRP) therapy. It aims to see which treatment works best to relieve symptoms.
This study tests whether a new topical treatment, StrataMGT, can reduce symptoms of vulvar lichen sclerosus. It is for women with moderate to severe symptoms who are already using a stable topical prescription.
Hear when a new Lichen Sclerosus Lesion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.